GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Sep. 2015 was $-1,495 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2015 was $-6,423 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends increased from Mar. 2015 ($-1,442 Mil) to Jun. 2015 ($-1,994 Mil) but then declined from Jun. 2015 ($-1,994 Mil) to Sep. 2015 ($-1,495 Mil).
GlaxoSmithKline PLC's annual payment of dividends declined from Dec. 2012 ($-6,438 Mil) to Dec. 2013 ($-6,023 Mil) but then increased from Dec. 2013 ($-6,023 Mil) to Dec. 2014 ($-6,335 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2015 was -1491.39280125 (Dec. 2014 ) + -1442.45142003 (Mar. 2015 ) + -1993.7694704 (Jun. 2015 ) + -1495.39877301 (Sep. 2015 ) = $-6,423 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data